✦ LIBER ✦

9403 Eribulin mesylate (E7389) in patients with leiomyosarcoma (LMS) and other (OTH) subtypes of soft tissue sarcoma (STS): a Phase II study from the European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC 62052)

✍ Scribed by Schöffski, P.; Hartmann, J.T.; Hohenberger, P.; Krarup-Hansen, A.; Wanders, J.; Hayward, C.; Druyts, D.; Van Glabbeke, M.; Sciot, R.; Blay, J.Y.

Book ID: 123055909
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 51 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71991-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of ET-743 in Advanced Sof

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

✍ Le Cesne, A. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

Brostallicin, an agent with potential ac

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

✍ Michael Leahy; Isabelle Ray-Coquard; Jaap Verweij; Axel Le Cesne; Florence Duffa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Brostallicin versus doxorubicin as first

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

✍ Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 758 KB

1260 Multicenter parallel phase II trial

1260 Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)

✍ P. Schöffski; J.Y. Blay; J. DeGreve; E. Brain; J.P. Machiels; J.C. Soria; S. Sle 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB